Internal Medicine, Endocrinology, Diabetes, & Metabolism · Southgate, MI
NPI
1346446143
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
15125 Northline Rd
Southgate, MI, 48195
Phone (734) 282-3138
Groups this clinician bills Medicare through
Medicare paid, 2024
$145K
1,874 services
Medicare patients, 2024
855
Average age 73
Drug cost, 2024
$5.6M
12,404 prescriptions
Company payments, 2025
$4,136
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nadia Khoury was code 99214 (office e&m - established), 474 times for 327 patients. In total Nadia Khoury billed 1,874 services in 24 codes, and Medicare paid $145K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 474 | 327 | $92.60 | $44K |
| 99213 Office E&M - Established | Office | 368 | 314 | $60.97 | $22K |
| 99232 Hospital E&M - Subsequent | Facility | 289 | 106 | $63.24 | $18K |
| 99231 Hospital E&M - Subsequent | Facility | 250 | 95 | $40.15 | $10K |
| 99222 Hospital E&M - Initial | Facility | 112 | 102 | $105.44 | $12K |
| 99215 Office E&M - Established | Office | 105 | 88 | $134.21 | $14K |
| 99223 Hospital E&M - Initial | Facility | 60 | 58 | $137.54 | $8,253 |
| 95251 Test - Miscellaneous | Office | 48 | 43 | $27.25 | $1,308 |
| 76536 Ultrasound - Nonspecific | Office | 36 | 35 | $79.91 | $2,877 |
| 99205 Office E&M - New | Office | 26 | 26 | $157.89 | $4,105 |
| 99204 Office E&M - New | Office | 25 | 25 | $119.76 | $2,994 |
| 99212 Office E&M - Established | Office | 24 | 24 | $32.39 | $777 |
| 99233 Hospital E&M - Subsequent | Facility | 17 | 16 | $96.18 | $1,635 |
By year: 2022 $149K for 1,922 services; 2023 $144K for 1,934 services; 2024 $145K for 1,874 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nadia Khoury prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,974 prescriptions and refills. In total Nadia Khoury wrote 12,404 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,974 | 5,554 | 709 | $25K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 524 | 1,435 | 233 | $133K |
| Metformin Hcl Generic | 501 | 1,430 | 181 | $4,942 |
| Ozempic Semaglutide | 500 | 1,160 | 167 | $1.1M |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 398 | 1,034 | 196 | $55K |
| Humalog Kwikpen U-100 Insulin Lispro | 333 | 906 | 150 | $147K |
| Jardiance Empagliflozin | 329 | 855 | 120 | $477K |
| Atorvastatin Calcium Generic | 321 | 896 | 117 | $4,389 |
| Novolog Flexpen Insulin Aspart | 317 | 723 | 149 | $123K |
| Losartan Potassium Generic | 261 | 783 | 100 | $3,645 |
| Glimepiride Generic | 229 | 643 | 91 | $2,080 |
| Rosuvastatin Calcium Generic | 226 | 612 | 83 | $4,123 |
| Trulicity Dulaglutide | 224 | 445 | 73 | $416K |
| Glipizide Generic | 216 | 600 | 85 | $3,284 |
| Lisinopril Generic | 204 | 575 | 78 | $1,452 |
Brand drugs: 5,015 claims; generic drugs: 6,376 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nadia Khoury $4,136 ($4,136 in general payments such as food, travel and fees) from 36 companies. The largest payer was Tandem Diabetes Care, Inc. with $338.
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. TNDM | 11 | $338 |
| Novo Nordisk Inc NVO | 22 | $334 |
| Amgen Inc. AMGN | 17 | $296 |
| Lilly USA, LLC LLY | 19 | $266 |
| Neurocrine BioSciences, Inc. NBIX | 6 | $252 |
| Abbott Laboratories ABT | 13 | $229 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $185 |
| Madrigal Pharmaceuticals MDGL | 8 | $182 |
| Dexcom, Inc. DXCM | 8 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $171 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.